Extract
We are pleased with the recommendation made by Khaleva et al. [1] to include a patient-centred approach to core outcome measures in severe asthma. The role of medicine has been described as “to cure sometimes, to heal often and to comfort always”, but to do this well requires us to really understand the patient who has the disease rather than the disease the patient has (William Osler).
Abstract
There is a need for more comprehensive measures of quality of life in severe asthma and the Severe Asthma Questionnaire provides a validated patient-centred core outcome measure for clinicians https://bit.ly/3Bo936f
Footnotes
Conflict of interest: D. Davies has nothing to report. J.W. Lanario reports non-promotional research grants from GSK, AZ and Teva outside the submitted work. R.C. Jones reports non-promotional research grants from GSK, AZ and Teva, outside the submitted work, and personal fees from GSK, Novartis and Optimum Patient Care. M.E. Hyland reports non-promotional research grants from GSK, AZ and Teva, outside the submitted work, and personal fees from GSK. M. Masoli reports a non-promotional research grant from GSK, outside the submitted work, and personal fees from GSK and AZ. J.W. Lanario, M.E. Hyland, R.C. Jones and M. Masoli are co-creators of the SAQ with the University of Plymouth and University Hospitals Plymouth NHS Trust.
- Received November 30, 2022.
- Accepted December 4, 2022.
- Copyright ©The authors 2023. For reproduction rights and permissions contact permissions{at}ersnet.org